AMRUTANJAN Aktienübersicht
Amrutanjan Health Care Limited produziert, liefert und vertreibt ayurvedische Schmerzsalben und Frauenhygieneprodukte.
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 0/6 |
| Künftiges Wachstum | 0/6 |
| Vergangene Leistung | 2/6 |
| Finanzielle Gesundheit | 5/6 |
| Dividenden | 4/6 |
Amrutanjan Health Care Limited Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | ₹768.70 |
| 52-Wochen-Hoch | ₹862.60 |
| 52-Wochen-Tief | ₹563.90 |
| Beta | 0.78 |
| 11 Monat Veränderung | -6.95% |
| 3 Monate Veränderung | 2.56% |
| 1 Jahr Veränderung | 24.76% |
| 33 Jahre Veränderung | -6.40% |
| 5 Jahre Veränderung | 128.34% |
| Veränderung seit IPO | 1,563.49% |
Aktuelle Nachrichten und Updates
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17Recent updates
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings
May 31Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29Aktionärsrenditen
| AMRUTANJAN | IN Pharmaceuticals | IN Markt | |
|---|---|---|---|
| 7D | -4.1% | 1.5% | 1.3% |
| 1Y | 24.8% | 59.4% | 45.4% |
Rendite im Vergleich zur Industrie: AMRUTANJAN unter dem Niveau der Branche Indian Pharmaceuticals, die im vergangenen Jahr eine Rendite von 59% erzielte.
Rendite vs. Markt: AMRUTANJAN hinter dem Markt Indian zurück, der im vergangenen Jahr eine Rendite von 45 erzielte.
Preisvolatilität
| AMRUTANJAN volatility | |
|---|---|
| AMRUTANJAN Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 3.9% |
Stabiler Aktienkurs: AMRUTANJAN hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.
Volatilität im Zeitverlauf: AMRUTANJANDie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1893 | 634 | Sambhu Sivalenka | www.amrutanjan.com |
Amrutanjan Health Care Limited produziert, liefert und vertreibt ayurvedische Schmerzsalben und Frauenhygieneprodukte. Das Unternehmen ist in den Segmenten OTC-Produkte, Getränke und Sonstige tätig. Es bietet Produkte zur Schmerzbehandlung an, darunter Schmerzbalsame und -Roll-ons, Rückenschmerz-Roll-ons, Pflaster, Körperschmerz-Gele und Gelenk-Muskelsprays.
Amrutanjan Health Care Limited's Grundlagenzusammenfassung
| AMRUTANJAN grundlegende Statistiken | |
|---|---|
| Marktanteil | ₹22.20b |
| Gewinn(TTM) | ₹425.73m |
| Umsatz(TTM) | ₹4.27b |
52.1x
Kurs-Gewinn-Verhältnis5.2x
Kurs-Umsatz-VerhältnisIst AMRUTANJAN zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| AMRUTANJAN Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | ₹4.27b |
| Kosten der Einnahmen | ₹2.15b |
| Bruttogewinn | ₹2.12b |
| Sonstige Ausgaben | ₹1.69b |
| Umsatz | ₹425.73m |
Zuletzt gemeldete Gewinne
Jun 30, 2024
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 14.73 |
| Bruttomarge | 49.61% |
| Nettogewinnspanne | 9.97% |
| Schulden/Eigenkapital-Verhältnis | 0.6% |
Wie hat sich AMRUTANJAN auf lange Sicht entwickelt?
Historische Performance und Vergleiche